Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM39E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,061
Award facts
- Contract value 100% obligated
- $19,061.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,061.12 to AmerSourceBergen Drug Corp for the supply of Renflexis 100 mg vials, a biosimilar medication used in the treatment of inflammatory conditions. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by January 14, 2026. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through its federal contracts, spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Renflexis exemplifies the company's critical role in supplying essential pharmaceutical commodities to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM39E?
SPE2DR26FM39E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM39E worth?
The government has obligated $19,061 on SPE2DR26FM39E.
Is contract SPE2DR26FM39E an order under another contract?
Yes. SPE2DR26FM39E is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM39E competed?
The extent of competition for SPE2DR26FM39E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award